Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM x anti-CD3): a phase I study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples